Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

In an interview with HT Lifestyle, Dipak Shah, Research Scientist at Himalaya Wellness Company, shared, “Gum disease affects ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Rheumatoid arthritis (RA) is the most common form of chronic inflammatory arthritis, characterized by synovitis and ...

At-risk individuals who progress to rheumatoid arthritis (RA) have a distinctive gut microbial composition, according ...

Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators ...

University of Leeds-led research has identified specific changes in the gut microbiome of individuals at risk of rheumatoid arthritis, potentially discovering disease onset mechanisms.

Grand Rapids Community College’s dental hygiene program highlights the link between oral and systemic health, emphasizing the ...

Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.